Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 18/20 | 0.60 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9729637 | 0.85 | ALOX5 (0.80) | ALOX5ALOX12PTGS1PTGS2ALDH1A1 | |
| SCHEMBL6165724 | 0.79 | ALDH1A1 (0.45) | ALOX5ALDH1A1KMT2A | |
| SCHEMBL9729583 | 0.75 | ALOX5 (1.00) | ALOX5ALOX12PTGS1PTGS2 | |
| SCHEMBL9729699 | 0.74 | ALOX5 (1.00) | ALOX5ALOX12PTGS1PTGS2 | |
| SCHEMBL6168726 | 0.74 | ALDH1A1 (0.44) | ALDH1A1KMT2A | |
| SCHEMBL6008413 | 0.72 | ALOX5 (1.00) | ALOX5ALOX12PTGS1PTGS2 | |
| SCHEMBL9729661 | 0.72 | ALOX5 (1.00) | ALOX5ALOX12PTGS1PTGS2 | |
| SCHEMBL6166743 | 0.72 | ALDH1A1 (0.42) | ALDH1A1KMT2A | |
| SCHEMBL9730189 | 0.69 | ALOX5 (1.00) | ALOX5ALOX12PTGS1PTGS2 | |
| SCHEMBL9729534 | 0.69 | ALOX5 (0.74) | ALOX5ALOX12PTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1044974-B1 | N-HYDROXYUREA DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | NIKKEN CHEMICALS CO LTD (JP) | 2005-07-20 | — | — | EP | claimed |
| EP-1044974-A1 | N-HYDROXYUREA DERIVATIVE AND MEDICINE CONTAINING THE SAME | Nikken Chemicals Company, Limited (JP) | 2000-10-18 | — | — | EP | claimed |
| JP-11209376-A | — | — | None | — | — | JP | disclosed |
| EP-1044974-B1 | N-HYDROXYUREA DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | NIKKEN CHEMICALS CO LTD (JP) | 2005-07-20 | — | — | EP | disclosed |
| EP-1044974-B1 | N-HYDROXYUREA DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | NIKKEN CHEMICALS CO LTD (JP) | 2005-07-20 | — | — | EP | disclosed |
| EP-1044974-A4 | N-HYDROXYUREA DERIVATIVE AND MEDICINE CONTAINING THE SAME | NIKKEN CHEMICALS CO LTD (JP) | 2003-01-22 | — | — | EP | disclosed |
| JP-2002020289-A | PROSTAGLANDIN E2 PRODUCTION PROMOTER | NIKKEN CHEM CO LTD | 2002-01-23 | — | — | JP | disclosed |
| JP-2002020288-A | LEUKOCYTIC INFILTRATION INHIBITOR | NIKKEN CHEM CO LTD | 2002-01-23 | — | — | JP | disclosed |
| US-6291482-B1 | THROMBOXANE SYNTHASE INHIBITORY ANTI-INFLAMMATORY DRUG COMPRISING N-HYDROXY-N-(6-(3-PYRIDYMETHYL)-2H-1-BENZOPYRAN-3-YLMETHYL)URE A; ANTIALLERGIC, ANTIASTHMATIC | NIKKEN CHEMICALS CO., LTD (JP) | 2001-09-18 | — | — | US | disclosed |
| US-6291482-B1 | THROMBOXANE SYNTHASE INHIBITORY ANTI-INFLAMMATORY DRUG COMPRISING N-HYDROXY-N-(6-(3-PYRIDYMETHYL)-2H-1-BENZOPYRAN-3-YLMETHYL)URE A; ANTIALLERGIC, ANTIASTHMATIC | NIKKEN CHEMICALS CO., LTD (JP) | 2001-09-18 | — | — | US | disclosed |
| EP-1044974-A1 | N-HYDROXYUREA DERIVATIVE AND MEDICINE CONTAINING THE SAME | Nikken Chemicals Company, Limited (JP) | 2000-10-18 | — | — | EP | disclosed |
| EP-1044974-A1 | N-HYDROXYUREA DERIVATIVE AND MEDICINE CONTAINING THE SAME | Nikken Chemicals Company, Limited (JP) | 2000-10-18 | — | — | EP | disclosed |
| JP-H11209376-A | N-HYDROXYUREA DERIVATIVE AND PHARMACEUTICAL CONTAINING THE SAME | NIKKEN CHEM CO LTD | 1999-08-03 | — | — | JP | disclosed |
| WO-1999024426-A1 | N-HYDROXYUREA DERIVATIVE AND MEDICINE CONTAINING THE SAME | NIKKEN CHEMICALS CO., LTD. (JP) | 1999-05-20 | — | — | WO | disclosed |